This week the final stage - the basket of medicines 2019 - Shabbat Square.
Health. Last Thursday, the last meeting took place before the final discussion marathon of the basket committee.
Among the drugs that reached the stages of the advanced discussions and are expected to be included in the basket are drugs for the treatment of cancer, including: "Impinzi" - a drug for stage III lung cancer patients who are still in the stage of healing, "Kitaroda" for some lung cancer patients and " EGFR. The drug "Perjeta" for breast cancer patients, designed to prevent the recurrence of the disease, the combination of the drugs "McKinst" and "Tafinler" for cancer patients melanoma with BRAF mutation and "opiate", technology for the treatment of brain cancer - "Naratinib" for the treatment of patients with breast cancer Her2 positive, which is also positive for hormonal receptors, in women with a high risk of relapse.
In the field of cardiology, drugs such as perluent and rapata have been included to lower cholesterol for patients with other drugs that do not help them, and anticoagulants to prevent stroke and pulmonary embolism. With a new mechanism of action, an antibody to PCSK9 protein, a protein that inhibits the removal of "bad" cholesterol from the blood.
In the field of hemato-oncology, breakthrough technologies ("Yiscarta" and "Kymara") went into the final stages of treatment for patients with blood cancer, who were not helped by any treatment. The treatment includes genetic engineering of cells of patients in a laboratory abroad and their return to the body in order to fight cancer.The treatments are considered effective, but their price is particularly high, and the drugs "Imberovica" and "Drzlex" for patients with blood cancer will be discussed in the next stage.
In the field of gastroenterology, the new technology called Darvadstroce - an innovative treatment for stem cells in complex preinal fistulas in Crohn's patients - has reached the final stage of discussions.
Other treatments that have reached the final stages include: Pulpicent - for patients with atopic dermatitis, a vision survey for toddlers in the kindergartens, ILARIS for family Mediterranean fever, Chantix for non-smoking cessation drugs, A drug for ADHD, a "drug" for patients with hemophilia and even Botox for the treatment of chronic migraines.
On the other hand, the drugs for weight loss, Bellevue and Sussex, will not go up to the next stage, as does the "Slinkero" alcohol rehabilitation. The drug "Imovig" for the prevention of migraines will also be postponed to next year.
Other treatments that have been left out include: MRI-guided targeted ultrasound for Parkinson's disease, early detection of lung cancer for smokers, funding for ambulance travel for people suspected of having an unexplained heart attack or stroke, and expanding funding for treatments at the Dead Sea for psoriasis patients.
Still outside the last marathon of discussions: eyeglasses for children ages 0-8, early mammography eligibility for early detection of breast cancer from age 40, and subcutaneous ECG for diagnosis of arrhythmia after stroke
Health. Last Thursday, the last meeting took place before the final discussion marathon of the basket committee.
Among the drugs that reached the stages of the advanced discussions and are expected to be included in the basket are drugs for the treatment of cancer, including: "Impinzi" - a drug for stage III lung cancer patients who are still in the stage of healing, "Kitaroda" for some lung cancer patients and " EGFR. The drug "Perjeta" for breast cancer patients, designed to prevent the recurrence of the disease, the combination of the drugs "McKinst" and "Tafinler" for cancer patients melanoma with BRAF mutation and "opiate", technology for the treatment of brain cancer - "Naratinib" for the treatment of patients with breast cancer Her2 positive, which is also positive for hormonal receptors, in women with a high risk of relapse.
In the field of cardiology, drugs such as perluent and rapata have been included to lower cholesterol for patients with other drugs that do not help them, and anticoagulants to prevent stroke and pulmonary embolism. With a new mechanism of action, an antibody to PCSK9 protein, a protein that inhibits the removal of "bad" cholesterol from the blood.
In the field of hemato-oncology, breakthrough technologies ("Yiscarta" and "Kymara") went into the final stages of treatment for patients with blood cancer, who were not helped by any treatment. The treatment includes genetic engineering of cells of patients in a laboratory abroad and their return to the body in order to fight cancer.The treatments are considered effective, but their price is particularly high, and the drugs "Imberovica" and "Drzlex" for patients with blood cancer will be discussed in the next stage.
In the field of gastroenterology, the new technology called Darvadstroce - an innovative treatment for stem cells in complex preinal fistulas in Crohn's patients - has reached the final stage of discussions.
Other treatments that have reached the final stages include: Pulpicent - for patients with atopic dermatitis, a vision survey for toddlers in the kindergartens, ILARIS for family Mediterranean fever, Chantix for non-smoking cessation drugs, A drug for ADHD, a "drug" for patients with hemophilia and even Botox for the treatment of chronic migraines.
On the other hand, the drugs for weight loss, Bellevue and Sussex, will not go up to the next stage, as does the "Slinkero" alcohol rehabilitation. The drug "Imovig" for the prevention of migraines will also be postponed to next year.
Other treatments that have been left out include: MRI-guided targeted ultrasound for Parkinson's disease, early detection of lung cancer for smokers, funding for ambulance travel for people suspected of having an unexplained heart attack or stroke, and expanding funding for treatments at the Dead Sea for psoriasis patients.
Still outside the last marathon of discussions: eyeglasses for children ages 0-8, early mammography eligibility for early detection of breast cancer from age 40, and subcutaneous ECG for diagnosis of arrhythmia after stroke
This week the final stage - the basket of medicines 2019 - Shabbat Square.
Reviewed by Health Tips
on
July 03, 2019
Rating:
Reviewed by Health Tips
on
July 03, 2019
Rating:
No comments: